A 173-patient randomized trial in HFrEF (LVEF ≤35%) with LBBB (QRS ≥130 ms) showed CSP was inferior to BiVP for a hierarchical 12‑month composite endpoint. Worse outcomes with CSP were reflected by an ...
Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging ...
Two multicenter trials drew different conclusions about the value of conduction system relative to biventricular pacing for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results